Study: Lowering cholesterol during melanoma immunotherapy
Part of Cancer, Heart & circulation, Skin clinical trials.
This study tests whether giving aggressive cholesterol-lowering medication to people starting immunotherapy for melanoma can improve heart health. It may help reduce the risk of heart problems during cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 55 or older, or a woman aged 65 or older.
- You have been diagnosed with melanoma and are about to start immunotherapy (drugs like PD-1, PD-L1, CTLA-4, or LAG3 inhibitors).
- You have not had any prior major heart events (heart attack, stroke, or heart surgery).
- You can have a heart scan called CCTA, meaning you have no allergies to contrast dye, no serious kidney problems, and no uncontrolled irregular heartbeat.
- Your fasting LDL "bad" cholesterol is less than 190 mg/dL.
- Your initial heart scan shows some plaque but no severe blockages.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether taking a cholesterol medicine called a statin can slow the buildup or worsening of coronary artery plaque in people with melanoma who are receiving checkpoint inhibitor (immunotherapy) treatment. It mainly looks at heart scans over time to see if statins change the progression of coronary atherosclerosis.
This study tests whether the statin drug atorvastatin can prevent immunotherapy from worsening artery plaque in people with melanoma. It aims to lower the risk of heart problems caused by treatment.
This study is looking at whether a special PET scan (FDG PET/CT) and a blood test that measures ctDNA (cancer DNA in the blood) can help predict how well immune checkpoint inhibitors work in people with advanced melanoma. If you are planning to get treatment with immunotherapy drugs like ipilimumab, nivolumab, or pembrolizumab, you may be able to join.
This study looks at how certain cancer drugs (called immune checkpoint inhibitors) interact with other medicines in the body. It aims to help doctors understand how to safely combine these treatments.
This trial studies whether eating a high-fiber diet can improve how well immunotherapy works against melanoma by affecting gut bacteria. If you have melanoma and are starting or have recently started immunotherapy, this study may be relevant.
This trial tests a program that helps melanoma patients starting immunotherapy track their side effects and get faster access to specialists. The goal is to improve symptom management.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.